Issam Awad to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Issam Awad has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.760
-
Growth of PIK3CA-driven cerebral cavernous malformations does not require microbiome stimulation. JCI Insight. 2026 Sep 08; 11(17).
Score: 0.236
-
Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations. Transl Stroke Res. 2025 Jun; 16(3):859-867.
Score: 0.205
-
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021 06; 594(7862):271-276.
Score: 0.164
-
Recurrent somatic copy number alterations in resected cerebral cavernous malformations. Hum Genomics. 2025 12 09; 20(1):12.
Score: 0.057
-
Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysis. J Stroke Cerebrovasc Dis. 2024 Jul; 33(7):107699.
Score: 0.050
-
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice. Stroke. 2023 11; 54(11):2906-2917.
Score: 0.048